
Indiana regulators are considering the state's first sanctioned hospital monopoly, following similar mergers under scrutiny in other states. A study has highlighted that antitrust enforcement of hospital mergers often falls short. This development comes as the Federal Trade Commission (FTC) recently failed in its bid to halt the Novant-CHS merger, raising concerns about the effectiveness of regulatory oversight in preventing monopolistic practices in the healthcare sector. Indiana weighs hospital monopoly as officials elsewhere scrutinize similar deals. Court Denies FTC Bid to Halt Novant-CHS Deal.
Indiana regulators could usher in the state’s first sanctioned hospital monopoly, following similar mergers under scrutiny in other states. @samanthann reports ⤵️ https://t.co/ghRP8G8lqd
Court Denies FTC Bid to Halt Novant-CHS Deal https://t.co/brmKheGxcz #FTC #Health #Merger @McDermottLaw https://t.co/p6rWWdMjFy
Indiana regulators could usher in the state’s first sanctioned hospital monopoly, following similar mergers under scrutiny in other states. @samanthann reports for KFF Health News & @USATODAY https://t.co/si2gADizk8




